|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3082957 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14871139.3 |
| Europos patento paraiškos padavimo data | 2014-12-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/071728 |
| Data | 2014-12-19 |
| (87) | Numeris | WO 2015/095829 |
| Data | 2015-06-25 |
| (30) | Numeris | Data | Šalis |
| 201361919638 P | 2013-12-20 | US |
| (72) |
SAHA, Saurabh , US
WELSCH, Dean , US
DECRESCENZO, Gary , US
ROIX, Jeffrey James , GB
|
| (73) |
Biomed Valley Discoveries, Inc. ,
4435 Main Street Suite 550, Kansas City, Missouri 64111,
US
|
| (54) | CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS |
| CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS |